GT
GOA Therapeutics Corp
SEC filingPharmaceuticals · West Palm Beach, FL
Amount raised$300Ksold at filing
Total offering$225M$224.7M still open
Investors in the raise1count reported to the SEC
FiledNov 5, 2026first sale Oct 22, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew AltschulerExecutive Officer, Director
Tami BarrExecutive Officer, Director
Dean HakansonExecutive Officer
David LandesmanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.